This inventor holds 1 USPTO granted patent and 8 published patent applications. Top assignees: The Brigham and Women's Hospital, Inc., The Broad Institute, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Veronika Shoba: Innovator in Chimeric Molecules
Introduction
Veronika Shoba is a distinguished inventor based in Cambridge, MA (US). She has made significant contributions to the field of biochemistry, particularly in the development of chimeric molecules that have potential applications in treating various diseases.
Latest Patents
Veronika holds a patent for "Bifunctional chimeric molecules for labeling of kinases with target binding moieties and methods of use thereof." This patent describes chimeric small molecules that serve as modifiers of target substrates. The formula A-L-E-B or A-L-E-L-B is utilized, where A represents a kinase binding moiety, B is a target binding moiety, L and L are linkers, and E is an electrophilic reactive group. These molecules can facilitate substrate modifications, such as post-translational modifications to targets that are not the natural substrate of the kinase. Consequently, they hold promise for treating or preventing various diseases or disorders.
Career Highlights
Throughout her career, Veronika has worked with notable institutions, including the Broad Institute, Inc. and Brigham and Women's Hospital, Inc. Her work has been pivotal in advancing the understanding and application of chimeric molecules in biomedical research.
Collaborations
Veronika has collaborated with esteemed colleagues, including Uttam Dhawa and Santosh Chaudhary, contributing to a rich exchange of ideas and innovations in her field.
Conclusion
Veronika Shoba's innovative work in the development of chimeric molecules exemplifies her commitment to advancing biomedical science. Her contributions have the potential to impact the treatment of various diseases significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile